Overarching Theme

Transforming neurology: Embracing every brain 

Overarching Theme Gothenburg 2027

Treatment in neurology is a uniquely timely and important topic because, historically, neurology was viewed as a discipline where treatment options were limited or only addressed symptoms. The nature of many neurological disorders meant that, until recently, physicians could offer little beyond supportive care. However, advances in neuroscience have dramatically expanded therapeutic possibilities, driven by discoveries in genetics, immunology, neuroprotection, and precision medicine.

In the coming years, the pace of innovation is expected to accelerate further, opening new avenues for disease-modifying therapies, personaliszed interventions, and integrated digital health approaches. As a result, the capacity to achieve meaningful improvements in neurological health is greater than ever, making the evolving landscape of neurology treatment a critical subject for clinicians, researchers, and patients alike.  

Social_Media_Templates-3__1_.png

Focused Workshop 1

Saturday, 12 June 2027, 08:30–10:00

Bridging the gap in diversity within neurology

This focused workshop explores how biological, genetic, and social dimensions of diversity influence neurological health, research, and clinical practice. The session will examine how factors such as gender, ethnicity, social determinants, and genetic ancestry shape disease risk, diagnosis, and treatment outcomes across neurological disorders. Through three complementary lectures, speakers will address the intersection of health equity and neurology, highlight persistent biases and underrepresentation in research and care, and discuss how population genetics contributes to differences in disease susceptibility.

  • Diversity in neurology: The intersection of biology, identity and health equity
  • Gender and ethnicity biases in neurology research and practice: From stroke to Alzheimer’s disease
  • Large, nationwide studies to reveal genetics in neurological and neuropsychiatric disease

Focused Workshop 2

Sunday, 13 June 2027, 08:30–10:00

Personalized monitoring and interventions in neurology

This workshop will provide a critical overview of how genetic profiling, disease-specific pathophysiology, and technological advances are used to individualize therapeutic approaches in neurology. Presentations will focus on diagnostic technologies, targeted therapies, and highlight evidence, limitations, and ongoing gaps in the field.

  • Genetic profiling and tailored treatment plans for rare neurological disorders
  • Emerging roles of biomarkers and digital monitoring in cognitive disorders
  • Non-invasive brain stimulation in neurological and psychiatric diseases
  • Tailoring shunt therapy of normal pressure hydrocephalus

Symposium

Monday, 14 June 2027, 10:30– 12:30

The era of disease modification: Advances across Neurology

This symposium presents current developments and limitations in disease-modifying therapies for major neurological disorders. Speakers will address the transition from symptomatic to pathophysiology-targeted treatments, summarizing the evidence for clinical use and emerging biomarkers. Clinical relevance and critical knowledge gaps will be discussed across Alzheimer’s, multiple sclerosis, Parkinson’s disease, and epilepsy. 

  • Disease-modifying therapies in Alzheimer’s disease: The journey to and beyond amyloid
  • Neuroprotection and remyelination in Multiple Sclerosis: Targets, biomarkers, and clinical impact
  • Genetic modifiers in Parkinson’s disease
  • Redefining epilepsy care: From seizure suppression to targeting underlying mechanisms